Introduction
Cells communicate and exchange information by different mechanisms. They may communicate by (i) secreted growth factors, cytokines, chemokines and small molecular mediators (e.g., nucleotides, nitric oxide ions, bioactive lipids), (ii) cell-tocell adhesion contacts that are mediated by sets of specialized adhesion molecules and (iii) exchanging information by means of tunneling nanotubules. [1] [2] [3] [4] [5] [6] However, attention is now being focused on cell-to-cell communication that involves circular membrane fragments called microvesicles (MV), [7] [8] [9] [10] [11] [12] a mechanism that for many years has been largely overlooked.
MV are shed from the cell surface of normal healthy or damaged cells and 'hijack' from these cells both membrane components and engulfed cytoplasmic contents. Shedding of membrane-derived MV is a physiological phenomenon that accompanies cell activation and growth. [7] [8] [9] [10] [11] [12] [13] [14] Interestingly, rapidly growing cell lines tend to secrete more MV than slowly growing ones. Generally, the number of MV shed from cells increases upon (i) cell activation, (ii) hypoxia or irradiation, (iii) oxidative injury, (iv) exposure to proteins from an activated complement cascade and (v) exposure to shearing stress. [7] [8] [9] [10] [11] [12] [13] [14] MV shedding depends on an increase in cytosolic Ca 2 þ and degradation of the membrane skeleton. MV also originate from the endosomal membrane compartment after fusion of secretory granules with the plasma membrane, where they exist as intraluminal membrane-bound vesicles called exosomes. 15 These exosomes are released from the cells during exocytosis of secretory granules together with the proteins present inside these granules. MV are released from the surface membranes during membrane blebbing in a calcium flux-and calpain-dependent manner and are relatively large (100 nm-1 mm). In contrast, smaller exosomes that are more homogeneous in size (30-100 nm) are released from the endosomal compartment. Interestingly, it has been reported that tumor suppressor p53 is involved in inducing the secretion of exosomes from lung tumor cell lines in response to DNA damage. 16 MV contain numerous proteins and lipids similar to those present in the membranes of the cells from which they originate. Furthermore, as MV membranes engulf some cytoplasm during membrane blebbing, they may also contain proteins derived from it and mRNA. 17, 18 Moreover, they may 'hijack' infectious particles (e.g., human immuno deficiency virus (HIV) or prions) from the cytoplasm [19] [20] [21] [22] or possibly even whole intact organelles such as the mitochondria. 23 MV are released by various cell types and differ in composition depending on cell origin and status. MV derived from the activated blood platelets are called microparticles (MP) . 24 MV released during tissue development from the basolateral membrane of the cells that synthesize morphogens (and are carriers for these molecules) are called argosomes. 25 MV released by activated human polymorphonuclear leukocytes are described in the literature as ectosomes. 26 MV are normal constituents of blood plasma (5-50 mg/ml) and are secreted by leukocytes, endothelium, platelets and erythrocytes. In normal serum (during steady-state conditions), the order of abundance is platelet-derived MP (80%), endothelial MV (10%) and leukocyte-derived ectosomes (10%). 24, 27 The number of MV circulating in peripheral blood (PB) increases during cell injury, inflammation, thrombosis and platelet activation. [10] [11] [12] [13] [14] Thus their level is elevated in the PB of patients suffering from infection or cardiovascular disorders. [10] [11] [12] [13] [14] MV are also secreted by neoplastic cells and this explains why they circulate at higher levels in the PB of cancer patients. [28] [29] [30] Cancer MV may display molecular signatures typical of the malignant clone from which they originate.
It is likely that a substantial percentage of the so-called soluble receptors identified in biological fluids or molecules such as DNA or mRNA are in fact associated with circulating MV. [31] [32] [33] Hence, MV could serve as potential diagnostic markers in laboratory medicine and the development of new diagnostic strategies based on the analysis of number and molecular signature of circulating MV can be anticipated in the near future.
Pleiotropic and biological effects of MV
Generally, MV isolated from a given cell type vary in size and in the composition of phospholipids, proteins and other molecules. At the molecular level, formation of MV results from perturbation of the lipid symmetry of the cell membrane leading to surface expression of phosphatidylserine, which translocates from the inner leaflet of the cell membrane bilayer to the outer surface leaflet. 10, 34 This step is controlled by special enzymes called floppases, flippases and scramblases. 10 Furthermore, MV shedding is preceded by segregation and formation of cell membrane proteins in lipid rafts. This explains why MV are often enriched in proteins usually associated with membrane lipid rafts. 35, 36 MV interact with other cells and investigators have just begun to appreciate the fact that they are an integral part of the intercellular environment and important modulators of cell to cell communication. Figure 1 depicts different mechanisms by which MV influence the biology of the target cells. Accordingly, MV may (i) stimulate other cells by surface-expressed ligands acting as a 'signaling complex', (ii) transfer surface receptors from one cell to another, (iii) deliver proteins, mRNA and bioactive lipids into the target cells, (iv) serve as a vehicle for the transfer of infectious particles (e.g., HIV, prions) and finally (v) perhaps deliver intact organelles (e.g., mitochondria) to the cells under certain circumstances.
We propose that this MV-mediated cell-cell communication system emerged very early during evolution and was probably a kind of a template for the development of cell-cell interactions involving soluble bioactive mediators and fine-tuned ligandreceptor interactions. 10, 37 Supporting this idea is the fact that MV are secreted by unicellular organisms and play, for example, an important role in contact guidance, as for example, in Amoeba, where a migrating Amoeba leaves behind a trail of MV that is recognized by another Amoeba following in its footsteps. Below, we briefly review the possible ways in which MV can modulate the biology of the target cells.
MV as signaling complexes
As MV carry several signaling proteins and bioactive lipids, they can be envisioned as a kind of signaling complex and we will review the role of MV derived from different cell types in cell-tocell communication.
Argosomes -MV-expressing morphogens
MV play an important role in developmental signaling and morphogenesis of multicellular organisms. For example, it was found that during tissue patterning some cells establish developmental gradients by secreting Hedgehog (Hh), Wingless or Decapentlaplegic proteins, which are expressed on MV. Morphogen-enriched MV (argosomes) are dispersed from the producing cells to create a motomorphogen gradient crucial for proper tissue development. 25 Interestingly, the Hh proteins could also be expressed on MV derived from T-lymphocytes, and as reported in a recent study, they may induce megakaryocytic differentiation of early human hematopoietic cells. 10 It was proposed that MV can therefore be considered as vehicles for the transfer of morphogen-borne biological information to remote responsive cells, and thus contribute to the maintenance of tissue/organ homeostasis.
MP -platelet-derived MV
Most experimental work performed so far has been on MV, derived from activated platelets (MP). MP were in fact the first MV to be described in the literature 40 years ago. 38 The important physiological role of MP is in coagulation where they provide a surface for binding and assembling clotting factors owing to a high content of phosphatidylserine. 39 An inborn defect in MP formation known as Scott syndrome leads to defective blood clotting and impaired MP formation may also be implicated in the coagulation defects seen in Glanzmann's thromboasthenia or in Castaman's defect. However, besides coagulation, MP also play an important role in other biological processes. MP can be isolated for experimental purposes from platelets stimulated with agonists such as thrombin, adenosine diphosphate þ collagen, terminal complement complex C5b-9, calcium ionophore A23187 or from platelets exposed to high-stress shear forces. 40, 41 MP express several platelet-endothelium attachment receptors on their surface, for example, a IIb b 3 integrin (CD41), Ib and IaIIa and P-selectin (CD62P). 40, 41 Interestingly, there is evidence that a IIb b 3 integrin plays a role in MP formation. MP also contain bioactive lipids, including sphingosine 1-phosphate (S1P) and arachidonic acid (AA). It has been reported that MP trigger various biological responses after interaction with target cells; for example, they may activate endothelial cells, 41 polymorphonuclear leukocytes 42 and monocytes. 43 They may also stimulate cytokine secretion and tissue factor (TF) expression in endothelial cells, 44 inhibit apoptosis of polymorphonuclear leukocytes 45 and induce chemotaxis of U-937 cells. 40, 41 Our team has reported that MP affect many functions of normal and malignant human hematopoietic cells. 17, 18, 22, 37, [46] [47] [48] First, we observed that MP enhance the chemotactic responsiveness of hematopoietic stem/progenitor cells (HSPC; CD34 þ cells) as well as various myeloid and lymphoid cells to suboptimal doses of stromal-derived factor. Based on these observations, we suggested that MP present at high concentrations in inflammatory areas could modulate chemoattraction of immune cells (monocytes, natural killer (NK) cells, T-and B-lymphocytes) to damaged tissues. 40 The fact that they contain S1P and AA could explain the stimulatory influence of MP on chemotaxis. [49] [50] [51] We also found that MP increase the survival of human hematopoietic cells including human CD34 þ clonogenic progenitors. 37 Similarly, MP inhibited apoptosis in thrombopoietin-dependent UT-7 cells as assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay and intracellular staining for activated caspase-3. These findings were consistent with a recent report showing that MP or factors derived from them inhibited apoptosis in human polymorphonuclear leukocytes. 45 Under serum-free conditions, MP co-stimulate the proliferation of clonogenic normal human CD34 þ cells and hematopoietic cell lines. A potential candidate for this effect is CD40 ligand (CD154), which is expressed on the surface of MP and has been reported to accelerate immune and hematopoietic recovery after bone marrow transplantation. 52 We can not, however, exclude the possibility that there are other proteins or MP-derived bioactive lipids (S1P and/or unsaturated lipid acids) that could account for this phenomenon. In support of this, it has been shown that S1P stimulates the proliferation of human endothelial cells, 49, 50 and that unsaturated lipid acids increase the proliferation of hematopoietic progenitors. 53 These effects could be explained at the molecular level by the fact that MP activate certain signaling pathways in human cells. For example, MP have been found to stimulate PKC in U-937 cells in addition to propidium iodide-3 (PI-3) K, mitogenactivated protein kinase (MAPK)p42/44, p38 and c-jun NHZterminal kinase1 (JNK1). 43 Our investigations have corroborated these findings: we found that MP activated MAPKp42/44 and PI-3K-AKT in malignant and normal human hematopoietic cells. 37 Phosphorylation of MAPKp42/44 and AKT provides molecular evidence that MP interact with the target cells and activate several signaling cascades that increase both cell survival and proliferation. [49] [50] [51] 54 Most likely, MP contain components that alone or in combination are responsible for the effects observed, although the particular components responsible for each specific effect remain to be elucidated.
Our data using molecular filtration and heat inactivation suggest that the biological activity of MP is associated with highmolecular weight proteins and is only partly affected by protein digest and/or heat inactivation. 37 We postulate that it could be related partly to high-molecular weight, relatively temperaturestable proteins and partly to bioactive lipids conjugated with high-molecular weight proteins. Unsaturated acids, however, have been found to induce apoptosis 54 and inhibit proliferation 55 in several experimental systems. Hence, further work is needed to identify the constituents of MP that are responsible for increasing the survival of hematopoietic cells, and a better understanding of the role MP play in hematopoiesis could help us to develop novel therapeutic approaches.
MP released from activated platelets are also an important component of the tumor microenvironment ( Figure 2 ) and thus may affect cancer growth and metastasis. 47 The presence of MP in the tumor microenvironment may be explained by the fact that several types of cancer express TF leading to platelet activation and release of MP, which in turn may affect several aspects of tumor cell biology. 56 We studied the influence of MP on the biology/metastasis of cancer cells in more detail in experimental models of lung and breast cancers. 47 We found that MP stimulated the phosphorylation of MAPKp42/44 and serine/threonine kinase in these cells as well as the expression of membrane type 1-matrix metalloproteinase (MT1-MMP). MP chemoattracted some of the tumor cell lines, stimulated their proliferation, upregulated cyclin D2 expression and increased trans-Matrigel chemoinvasion. Furthermore, MP stimulated mRNA expression for angiogenic factors such as MMP-9, vascular endothelial growth factor, interleukin-8 and hepatocyte growth factor, as well as adhesion to fibrinogen and human umbilical vein endothelial cells. 47 Based on this evidence, MP seem to be important mediators of intercellular cross-talk between platelets and cancer cells, which we still do not fully understand. The exacerbating effects of high platelet counts on cancer progression could be explained, at least in part, by the action of MP and exosomes derived from them. [57] [58] [59] [60] [61] [62] [63] These data also support recent findings showing that the increased level of MP circulating in PB is a strong predictor of metastasis in patients with gastric cancer. 30 Again, more studies are needed to identify the specific MP components that exert these biological effects. Furthermore, better understanding of the role MP play in tumor progression and metastasis could help us to develop new therapeutic approaches. Moreover, special caution should be exercised in using platelet concentrates that are enriched in MP to treat cancer patients, as they can increase the risk of cancer metastasis.
47,48
Tumor cell-derived MV It is well known that media obtained from exponentially growing cell cultures and analyzed by fluorescence-activated cell sorter contain small particles that were usually interpreted as 'cell debris, cell dust or cell fragments'. These small fragments are detectable (in higher or lower concentrations depending on the cell line) in media derived from the cultures of even 'healthy looking' exponentially growing cells. 7 Electron microscopy studies revealed that this 'debris' is in fact enriched in MV. Thus, media conditioned by growing cells are a convenient source of MV for study of their biological effects. Similarly, MV are released in vivo from growing tumor cells and are present in the tumor microenvironment as well as circulate in the PB. 30, [57] [58] [59] [60] [61] [62] [63] On the basis of this, we identified MV as being important constituents of the tumor microenvironment ( Figure 2 ) and considered their role in tumor progression to merit more detailed investigation. Focusing on a lung cancer model, we first observed that human and murine lung cancer cell lines secrete MV in response to non-apoptotic doses of hypoxia, irradiation and chemotherapy. 47 MV derived from human cancer cells chemoattracted bone marrow-, lymph node-and lung-derived fibroblasts and endothelial cells and activated the phosphorylation of MAPKp42/44 and AKT in these stromal cells. Furthermore, they induced expression of leukemia inhibitory factor (LIF), oncostatin m (OSM), interleukin-11 (IL-11), vascular endothelial growth factor (VEGF) and MMP-9 in bone marrowand lung-derived fibroblasts. Moreover, conditioned media from bone marrow (BM) fibroblasts exposed to MV induced phosphorylation of signal transducers and activators of protein-3 proteins and chemoattracted small-lung cancer cells in an LIF-and OSM-dependent manner and, together with IL-11 and VEGF, activated osteoclasts and endothelial cells. MV from cancer cells embedded in Matrigel implants strongly stimulated angiogenesis. 64 Recently, it was reported that MV-expressing TF were strong inducers of VEGF secretion and stimulators of angiogenesis. 65 Similarly, analysis of exosomes secreted by mesothelioma cells revealed the presence of developmental endothelial locus-1 protein, which is a strong angiogenic factor involved in vascular development and angiogenesis. 66 Based on this, we postulate that tumor-and platelet-derived MV are constituents of the tumor microenvironment and play a pivotal role in tumor progression/metastasis and angiogenesis, which justifies directing resources toward the development of new therapeutic strategies directed against MV.
Role of MV in transferring receptors between the cells
The phenomenon of receptor transfer between cells by MV has been best studied in platelet-derived MP, which transfer plateletexpressed adhesion molecules to hematopoietic cells, increasing their adhesion to fibrinogen or endothelium. 37, 48 This is supported by the observation that MP can transfer the CD41 antigen (a IIb b 3 integrin) from platelets to endothelial cells. 12 In our work, we found that human CD34 þ HSPC obtained by leukapheresis are highly covered by MP. 48 The presence on these cells of MP (which transfer CD41, CXCR4, for example) may facilitate their homing and explain why mobilized PB cells obtained by leukapheresis engraft better than BM cells harvested during steady-state hematopoiesis. 48 A similar mechanism may be operating when we showed that MP derived from activated platelets transfer platelet-adhesion molecules (e.g., a IIb b 3 integrin) to the tumor cell surface. 47 This increases the adhesiveness of lung cancer cells to endothelium and their metastatic spread in vivo after injection into syngeneic mice. Intravenous injection of murine MP-covered Lewis lung cancer (LLC) cells into syngeneic mice resulted in significantly more metastatic foci in their lungs and LLC cells in their BM than in control animals that were injected with LCC cells not covered with MP. 47 An interesting phenomenon of MV-mediated transfer has recently been described for monocyte/macrophage-derived TF. 36 The monocyte/macrophage-derived MV circulated in PB and, besides P-selectin glycoprotein ligand-1 (PSGL-1), expressed mostly plasma TF. These MV not only activated platelets by stimulating them directly with PSGL-1 but also fused with them and transferred/incorporated TF into their membranes. This transfer mechanism promoted optimal coagulation by activated platelets.
Transfer of cell receptors could also explain why MV and MP play an important role in spreading HIV infection by sensitizing cells to infection by HIV-1. Although several factors modulate the infectability of hematopoietic cells by the HIV, among the most important are the expression of CD4 and virus coreceptors, which mediate virus binding to the cell surface and subsequently facilitate internalization of viral particles. 67 HIV-1 viruses enter cells after binding to the CD4 protein and one of several chemokine receptors. X4 (lymphotropic) viruses use the CXCR4 chemokine receptor and R5 (macrophage-tropic) viruses the CCR5 chemokine receptor as co-receptors for entry. The primary targets of HIV-1 infection are lympho/hematopoietic cells (T-lymphocytes, macrophages, megakaryocytes and dendritic cells), which express CD4 and one or both of these chemokine co-receptors. However, there is mounting evidence that, in addition to lympho/hematopoietic cells, other cell types such as endothelial cells, astrocytes and cardiomyocytes may also be susceptible to HIV-1 infection, and may be an important source of the virus in chronic infections. 68, 69 As these cells do not typically express HIV-related co-receptors on their surface, other mechanisms must play a role in their susceptibility to infection. This infectability by HIV may now be explicable by the notion that MV are transferring some of the HIV-entry coreceptors to these cells. Accordingly, it has recently been shown that MV derived from monocytes may transfer CCR5 between cells and are responsible for rendering these cells susceptible to R5 HIV infection. 70 A similar mechanism has been demonstrated by our team for MP that may transfer platelet-derived CXCR4 to the cells and render them susceptible to infection by X4 HIV. 22, 71 Thus, MV and MP could play an important role in spreading HIV infection by transferring HIV entry receptors. An interesting area for further investigation would be to determine whether receptors transferred by MV remain functional and retain their signaling properties after transfer.
MV deliver mRNA and proteins into cells
It has also been well documented that cell extracts may induce epigenetic changes in co-cultured target cells, although the mechanisms responsible are not clear. This phenomenon has been demonstrated, for example, permeabilized fibroblasts exposed to extracts from lymphocytic cells, after which the fibroblasts began to express various genes typical of lymphocytes.
72-74 A similar phenomenon was described for the cultures of murine HSPC exposed to extracts from damaged liver cells. 74 After exposure, HSPC began to express some genes specific for hepatocytes, a finding that supports the notion that proteins and mRNA molecules exogenously delivered to the cells may induce changes in target cells.
During their formation, MV become enriched in various molecules that are expressed in the cytoplasm of the cells from which they originate. Using a model of murine embryonic stem cell (ES)-derived MV, we obtained evidence that MV may in fact, contribute to epigenetic reprogramming of target cells. 4, 17 We observed that ES-derived MV in serum-free cultures significantly enhanced survival and improved the expansion of murine HSPC, upregulated the expression of markers for early pluripotent (Oct-4, Nanog and Rex-1) and early hematopoietic stem cells (Scl, HoxB4 and GATA 2), and induced phosphorylation of MAPKp42/44 and serine-threonine kinase AKT. Furthermore, molecular analysis revealed that ES-MV express Wnt-3 protein and are selectively highly enriched in mRNA for several pluripotent transcription factors compared to parental ES cells. More important, this mRNA could be delivered by ES-MV to target cells and translated into the corresponding proteins. 17 The biological effects of ES-MV were inhibited after heat inactivation or pretreatment with RNAse, indicating major involvement of the protein and mRNA components of ES-MV in the observed phenomena.
The phenomenon of cell reprogramming by MV requires further study in other cell types. It may, however, explain some of the transdifferentiation data that have been obtained in the presence of cell-cell co-cultures or of cells with cell extracts. It may also explain stem cell trans-dedifferentiation or plasticity data, which could be explained, at least in part, by changes in transplanted stem cells due to horizontal transfer of mRNA/ proteins from the damaged tissues.
Role of MV in HIV and prion transfer
As discussed above, HIV-entry receptors may be transferred to cells lacking these receptors rendering them susceptible to HIV infection. 22, 70 However, another MV-mediated mechanism of direct transfer of HIV into the cells is possible. Using an analogy from Greek mythology, we and others have postulated the 'Trojan horse mechanism' hypothesis of entry. 71, 75 A similar mechanism has also been described recently for infection of cells by prion molecules. In fact, recent studies using the dissociation-enhanced lanthanide fluoroimmunoassay showed that platelets and plasma are the main reservoir of cellassociated prion protein in human blood. 76 Similar studies also indicate that this protein is released from platelets obtained by apheresis during storage. 77 Evidence that these infectious prion particles are associated with platelet-derived MP suggests that the latter play a role in their spread. Further studies are needed to explore the extent to which MV and MP are implicated in the spread of other infectious agents.
MV transfer organelles between the cells?
An intriguing glimpse of how MV affect the biology of target cells was obtained in a model of cells defective in aerobic respiration, in which mitochondria and mitochondrial DNA were found to be transferred between the cells. 23 A likely mechanism for this phenomenon is the transfer of mitochondria between the cells by MV. Recently, it was postulated that some of the beneficial effects of stem cell infusions in rescuing myocardium damaged by infarct could be explained by MV transfer of intact fresh mitochondria from the infused cells into damaged cardiomyocytes. 78 Further studies are needed to determine whether other organelles (e.g., lysosomes, ribosomes) can be translocated in this manner under certain circumstances.
Role of MP in inflammation and thrombosis
MV circulating in PB increase in number during inflammation, and thrombotic complications occur in various states of cardiovascular pathology. 13 In these situations, MV exert various pleiotropic effects on the immune system and endothelium. MV may contain several mediators of inflammation or affect their formation. For example, MP may express IL-1b and promote synthesis of lysophosphophatidic acid. 79 They may also affect expression of various adhesion molecules on target monocytes and endothelial cells as well as induce production of several proinflammatory cytokines. In turn, stimulation of monocytes, endothelial cells, hepatocytes and smooth muscle cells with liposaccharide, tumor necrosis factor-a, IL-1 or terminal complement complex C5b-9 increases MV shedding by these cells. 80 Furthermore, cells that express MV-derived phosphatidylserine on the surface could be eliminated by NK cells and macrophages that express phosphatidylserine receptors. 81 Ectosomes, MV released by activated polymorphonuclear leukocytes (PMN), may also play an important role in inflammation. 82 Ectosomes activate and bind complement in vitro and express clusters of complement receptor 1 (CR1), which allows them to bind efficiently to opsonized bacteria. Myeloperoxidase and human leukocyte elastase, which are both usually stored within the azurophilic granules of PMN, have been found to colocalize on ectosomes together with CR1. 26, 83 Hence, ectosomes released by activated PMN at the site of inflammation may function as a well-organized element to localize antimicrobial activity onto opsonized surfaces. On the other hand, it has been suggested that neutrophil ectosomes increase secretion of TGF-b1 by macrophages and downmodulate their activation. Hence, release of ectosomes by neutrophils at early stages of inflammation may lead to its resolution.
Biological effects of microvesicles
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SPOTLIGHT
Finally, MV promote thrombosis in several ways. 10, 13 First, they are a source of TF, which initiates coagulation; second, they have a direct effect on endothelium (by impairing endothelial function by altering redox balance); and third, they provide phosphatidylserine, which efficiently binds coagulation factors. Finally, they activate platelets and monocytes. These unwanted effects of MP and MV are increasingly coming to light in patients with cardiovascular disorders. 13 
Role of MV in tumor progression
Numbers of circulating MV are increased in the PB of cancer patients and have been correlated in gastric cancer patients with increased metastasis and a worse prognosis. 30 As stated previously, evidence continues to grow that the tumor microenvironment is highly enriched in MV shed from cancer cells, platelets, monocytes and lymphocytes cells infiltrating the tumor tissue (Figure 2) . Thus, as we have shown in our review, MV are important but still insufficiently understood mediators of tumor growth, progression and metastasis. Moreover, tumor-derived MV stimulate secretion of several proangiopoietic factors by stromal fibroblasts, chemoattract and increase the proliferation of endothelial cells, and promote angiogenesis. 47 Furthermore, there is evidence that MV released by activated tumor cells can modulate the function of tumor-infiltrating lymphocytes. For example, some malignant cells such as melanoma may express Fas ligand on their surface, which becomes biologically active after binding to CD95 on T-lymphocytes and may then induce apoptosis. 84 This may be an escape mechanism whereby the cancer cells elude tumor-infiltrating lymphocytes.
Conversely, a recent study demonstrated a beneficial effect of MV secreted by some tumors in increasing the survival of tumorinfiltrating monocytes. 18 Tumor-derived MV may interact with these cells, altering their immunophenotype and biological activity. Accordingly, human cancer cell-line-derived MV can transfer various surface determinants (e.g., CCR6 and CD44v7/ 8) to monocytes, exert an antiapoptotic effect on them and activate AKT kinase (protein kinase B). This suggests a novel mechanism by which tumor-infiltrating macrophages may be affected by tumor cells not only by direct cell to cell contact and by soluble factors but also by MV. 18 Finally, since exosomes harbor major histocompatibility antigens, they may stimulate T-lymphocytes in an antigenspecific manner. Hence, tumor-derived exosomes could potentially be employed to stimulate immunological responses against malignant cells. 85 In fact, the effectiveness of immunization with tumor-derived MV is currently being investigated in appropriate animal experimental models in vivo. 85 On the other hand, exosomes do not seem to be linked only to inducing stimulatory responses in the immune system. There are reports that exosomes derived from a donor and given to a recipient before transplantation may induce tolerance rather than immunity and thus significantly prolong allograft survival. 10 Potential practical application of MV First, MV could find practical application as a diagnostic indicator. Their levels may correlate with and be a measure of inflammation, or be predictive of metastasis or thrombotic complications. Second, MV could be employed as a physiological vehicle (e.g., as a kind of liposome) to deliver various molecules to the cells. For example, it has been proposed that MV derived from normal red blood cells could transfer glycosylphosphatidylinositol-anchored protein decay-accelerating factor (CD55, DAF) and the membrane inhibitor of reactive lysis (CD59, MIRL) to erythrocytes of paroxysmal hemoglobinuria (PNH) patients who lack these proteins. 86 It was shown that when MV rich in CD55 and CD59 were collected from outdated normal red blood cell units and transfused into PNH patients, surface CD59 increased. 86 Third, painting the cell surface with MV expressing the desired receptors could find practical use for increasing cell homing after transplantation (e.g., MP) or sensitizing them to be transduced by viral vectors (e.g., MV expressing cell surface entry receptors for viral vectors). Finally, MV derived from tumor cells could be used in certain situations as tools to bolster the immune-response against neoplastic cells or, by contrast, to induce tolerance of the grafted organs. 10 
Modulation of MV secretion
As MV have potent proinflammatory effects and affect the function of endothelium and promote coagulation, they may play a role in the pathogenesis of cardiovascular diseases. Similarly, MV may enhance tumor progression and metastasis. This justifies the development of new strategies that will inhibit MV production by the cells or promote MV elimination from the PB.
First, MP formation could be inhibited by employing abciximab, an antagonist of a IIb b 3 integrin involved in triggering the vesiculation of platelets. 87 Second, as calcium flux is crucial for platelet vesiculation, MP formation could also be inhibited by calcium blockers. 88 A similar inhibitory effect on MV formation has been described after high-dose vitamin C therapy. 89 Third, because the production of MV depends on the formation of membrane lipid rafts, it is possible that inhibitors of membrane lipid raft formation (e.g., statins or polyene antibiotics) could reduce MV formation. One of the little-understood effects of statins on cardiovascular system could be explained by such inhibition of MV formation. 35 This concept, however, requires verification by further study in appropriate in vivo experimental models. Finally, since MV express phosphatidylserine on their surface, it may be possible to eliminate them from the PB using absorption columns containing Annexin-V matrix. Another important anti-MPdirected strategy would be to avoid transfusions of outdated platelets, 90, 91 particularly in cancer patients and those suffering from cardiovascular disorders.
In conclusion, the scientific community has made considerable progress to date in recognizing MV as important mediators of intercellular communication rather than irrelevant cell debris. We have already learned much about the biological effects of MV. Future steps would be to (i) explore their full potential diagnostic application, (ii) develop efficient strategies that will allow us to modulate their secretion in various clinical situations and finally (iii) employ MV as tools to modify the biological responses of cells. A new era of investigation and opportunity for drug development has begun!
